Teva's Symbicort generic backed for EU approval PMLiVE Symbicort and GlaxoSmithKline's rival product Advair/Seretide (fluticasone and salmeterol) have dominated the market for combination inhaled corticosteroids/beta agonists. However, the arrival of generics - as well as a new generation of combination ... |
